The famous RAND Health Insurance Experiment (RAND HIE) deals with the question how health insurance affects medical spending. The scientific essay The RAND Health Insurance Experiment, Three Decades Later (2013) by Aviva Aron-Dine, Liran Einav, and Amy Finkelstein, extracted from the Journal of Economic Perspective, forms the basis for this seminar paper. All facts regarding the primary experiment are taken from this essay.
It features a reexamination of the core findings of the RAND HIE with a state of the art perspective regarding the analysis of randomized experiments and the economics of moral hazard. Between 1974 and 1981, more than 5,800 individuals from about 2,000 households in six different locations across the United States participated in the RAND HIE and thereby received health insurance. The experiment randomly assigned families to health insurance plans with different levels of cost sharing and was representative of families with adults under the age of 62. The plans ranged from full coverage (“free care”) to plans with little coverage (5 percent) for the first approximately $4,000 (in 2011 dollars) incurred during a year.
The conduct and analysis of randomized experiments as well as the economic analysis of moral hazard in the context of health insurance were relatively novel fields of research back in the years of the RAND investigation. Nevertheless, the RAND results are highly esteemed when predicting the likely impact of health insurance reforms on medical spending or design-ing actual insurance policies. In the course of time, health spending has grown and the consequent pressure on the public sector confers additional significance to the RAND estimates.
The RAND HIE was funded by the US Department of Health, Education, and Welfare and cost roughly $295 million (in 2011 dollars). From a cost perspective alone, a replication of such an experiment is highly improbable.
In section two, the design of the RAND HIE is presented and complemented by a depiction of the key economic object of interest, namely the impact of health insurance on medical spending. Section three describes the experimental analysis, including the baseline regression. The core variable of interest, the treatment effect, is specified and validated. In section four, the price elasticity is derived and the application discussed. Section five emphasizes the raison d’être for a randomized experiment based on statistical evidence and additional literature.
Table of Contents
1. Introduction
2. The RAND Health Insurance Experiment
3. Experimental Analysis
3.1. Treatment Effects
3.2. Validation and Robustness
4. Price Elasticity
4.1. Empirical Background
4.2. Application and Problematic Nature
5. Raison d’être of an Experiment
5.1 Endogeneity Problem
5.2 Potential Outcome Model
5.3 Methodology
6. Conclusion
Research Objectives and Core Themes
This seminar paper examines the core findings of the RAND Health Insurance Experiment (RAND HIE) to analyze the impact of health insurance coverage on medical spending and the prevalence of moral hazard. It evaluates the robustness of the experimental results, discusses the methodological challenges of calculating price elasticity in the presence of non-linear insurance contracts, and explores the role of randomized social experiments in causal economic analysis.
- Analysis of randomized experimental design in health economics.
- Evaluation of consumer response to varying cost-sharing plans.
- Methodological challenges in deriving price elasticity for medical services.
- Quantification of bias from differential participation and reporting.
- Comparison of observational versus experimental causal inference.
Excerpt from the Book
3.1. Treatment Effects
By estimating the basic regression for various measures of healthcare utilization, λp indicates the treatment effect of the different plans relative to the free care plan. The treatment effect is the causal effect of cost sharing on healthcare utilization. The results are from an ordinary least squares regression (OLS) and reveal a consistent pattern of less spending in higher cost-sharing plans. The p-values imply the rejection of the null hypothesis that spending in the positive cost-sharing plans is equal to that in the free care plan. Furthermore, the total spending is broken down into inpatient (42 percent), indicating more serious and costly medical episodes, and outpatient spending (58 percent). This classification reemphasizes the pattern of lower spending in plans with higher cost sharing. The effect of cost sharing in an inpatient setting is consistently small and generally insignificant, implying more serious medical sequences to be less price sensitive – an essential and plausible causal inference of the treatment. Consequently, the null hypothesis of no differences in spending across plans for any in and outpatient spending is rejected. In addition to the classification of spending, the extent to which the effect of cost sharing might vary for those with higher medical expenditure is considered. In other words, a quantile regression is employed to estimate the above equation and subsequently determine the potential variation across the quantiles of medical spending. The results are concordant with a lower percentage treatment effect for higher-spending individuals. This is likely to stem from two factors. Firstly, the lower price responsiveness for inpatient spending. Secondly, the early obtainment of a zero percent coinsurance rate for high-spending individuals, regardless of the initial plan-assignment. (Aron-Dine et al., 2013)
Chapter Summaries
1. Introduction: Outlines the significance of the RAND Health Insurance Experiment as a foundational study for understanding the impact of insurance on medical spending and introduces the scope of this seminar paper.
2. The RAND Health Insurance Experiment: Describes the design of the study, including the stratified random assignment of families into six different insurance plans with varying cost-sharing rates.
3. Experimental Analysis: Details the baseline regression approach used to estimate treatment effects and validates the experimental results against potential biases.
4. Price Elasticity: Discusses the transformation of experimental treatment effects into a single elasticity estimate and addresses the complexities caused by non-linear insurance contracts.
5. Raison d’être of an Experiment: Explains the necessity of randomized controlled trials in economic research by highlighting the endogeneity problems inherent in observational studies and the application of the Potential Outcome Model.
6. Conclusion: Summarizes the key insights of the study, affirming the existence of moral hazard while acknowledging the limitations and uncertainties involved in out-of-sample extrapolations.
Keywords
RAND Health Insurance Experiment, RAND HIE, moral hazard, medical spending, price elasticity, randomized experiment, cost-sharing, causal analysis, econometrics, health insurance, outpatient spending, inpatient spending, treatment effect, endogeneity, Potential Outcome Model.
Frequently Asked Questions
What is the primary focus of this seminar paper?
The paper focuses on the RAND Health Insurance Experiment, specifically investigating how health insurance coverage affects medical spending and whether moral hazard exists in the healthcare market.
What are the central thematic fields covered in the work?
The central themes include experimental economics, health insurance design, consumer behavior under cost-sharing, and the statistical methods required to derive causal inferences from large-scale social experiments.
What is the core research question addressed by the RAND HIE?
The experiment aims to determine if more comprehensive health insurance leads to increased, potentially superfluous, doctor's visits, thereby quantifying the moral hazard effect.
Which scientific methods are primarily utilized in the analysis?
The paper utilizes regression analysis, specifically Ordinary Least Squares (OLS) and quantile regression, alongside the Rubin Causal Model (Potential Outcome Model) to establish causal relationships.
What topics are explored in the main part of the paper?
The main part covers the experimental design, the quantification of treatment effects, the derivation of price elasticity, the validation of results through the removal of biases, and a theoretical justification for using experiments in policy research.
Which keywords best characterize this work?
Key terms include RAND HIE, moral hazard, price elasticity, causal analysis, treatment effects, and randomized experiment.
How does the author address the issue of differential reporting in the experiment?
The author notes that researchers adjusted for differential filing of claims by scaling up outpatient spending for participants in different plans based on plan-specific underreporting percentages identified in contemporaneous inquiries.
What is the significance of the "Maximum Dollar Expenditure" limit in the study?
The Maximum Dollar Expenditure limit was a mechanism used to limit the financial exposure of participants, ensuring that the out-of-pocket costs remained within 5, 10, or 15 percent of a family's income.
Why is the price elasticity estimate of -0.2 considered to be complex?
It is complex because health insurance contracts are non-linear; the "price" of medical care changes as cumulative spending increases, making it difficult to define a single representative price for consumers.
- Arbeit zitieren
- Nina Schwenniger (Autor:in), 2015, A Review of the Rand Health Insurance Experiment. Statistics and Econometrics, München, GRIN Verlag, https://www.grin.com/document/300637
